Estrogen-receptor-positive Breast Cancer trials recruiting in Massachusetts

Fewer than 3 recruiting trials found.

All Estrogen-receptor-positive Breast Cancer trials nationally

Cities in Massachusetts

Recruiting trials in Massachusetts

• PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
  NCT07222215 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston